Advanced Science, 2026 Caspase‐3/GSDME‐Mediated Trophoblast Pyroptosis and Reciprocal Macrophage Polarization Contribute to Inflammation in Early‐Onset Preeclampsia Huang B., Deng W., Bi S. et al. Olink Explore 3072/384ObstetricsPathophysiologyPlasma | | | | |
Advanced Healthcare Materials, 2026 Uncovering the Adaptive Tumor Immunity Interactions from a Single‐Cell Level Liu T., Pang Y., Zhou C. et al. Olink Target 96 MouseOncologyTechnical EvaluationMouse Cell Supernatant | | | | |
Molecular Therapy, 2026 Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors Clubb J., Pakola S., Joenväärä S. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
Molecular Therapy, 2026 Dyslipidemia-associated natural IgM improves oncolytic virus TILT-123 efficacy through antibody-dependent enhancement in solid tumors Clubb J., Pakola S., Joenväärä S. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerum | | | | |
Signal Transduction and Targeted Therapy, 2026 Multiomics Mendelian randomization identifies serpin family G member 1 as a chronic obstructive pulmonary disease modulator Yi E., Cui J., Wang H. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma | | | | |
Cardiovascular Diabetology, 2026 Chronic kidney disease onset, progression, and cardiovascular outcomes: proteomics informs biology and risk stratification Zhang J., Yu H., Song X. et al. Olink Explore 3072/384CVDNephrologyPathophysiologyPatient StratificationPlasma | | | | |
Bioinformatics Advances, 2026 HDAnalyzeR: Streamlining Data Analysis for Biomarker Research Antonopoulos K., Johansson E., Kenrick J. et al. Olink Explore 3072/384OncologyWider Bioinformatics StudiesData SciencePlasma | | | | |
European Stroke Journal, 2026 Elevated acute-phase plasma levels of S100A12 [EN-RAGE] are associated with vascular recurrence after ischemic stroke Granelli B., Angerfors A., Furutjäll S. et al. Olink Target 96CVDNeurologyPatient StratificationPlasma | | | | |
Annals of Neurology, 2026 Neutrophil‐Secreted Enzymes and
ALS
Risk: Exploring a Potential Mechanistic Link Cao W., Yu L., Wang Z. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
Bone, 2026 Association between systemic redox balance and osteoporosis: prospective evidence, polygenic modification, and proteomic and inflammatory mediation in the UK Biobank Zhu Y., Liu D., Yin X. et al. Olink Explore 3072/384OrthopedicsPathophysiologyPlasma | | | | |
Annals of Hematology, 2026 Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia Hu K., Cheng Y., Xiao G. et al. Olink Target 96HematologyPathophysiologyPlasma | | | | |
Journal of Human Genetics, 2026 Meta-analyses of genome-wide association studies identify novel loci influencing Japanese white matter hyperintensities Asanomi Y., Mitsumori R., Yamakawa A. et al. Olink Target 96NeurologyAgingPathophysiologyPlasma | | | | |
Molecular Therapy Advances, 2026 The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans Ryberg E., Bergström F., Sten S. et al. Olink Explore 3072/384CVDPathophysiologyMonkey Plasma | | | | |
Medicine, 2026 Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study Liu K., Han X., Chen Y. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
European Heart Journal, 2026 Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study Kakizaki R., Biccirè F., Losdat S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Microorganisms, 2026 Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia Wen Y., Zhai Y., Sang S. et al. Olink Target 48 MouseInfectious DiseasesPathophysiologyMouse Balf | | | | |
Biomedicine & Pharmacotherapy, 2026 Integrated transcriptomic and proteomic profiling identifies an interferon-dependent inflammatory endotype in sepsis Fratea A., Riza A., Dumitrescu F. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Clinical Pharmacology in Drug Development, 2026 Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies Vendel A., Benichou O., Chang C. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Molecular Neurodegeneration Advances, 2026 Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12 Farias Quipildor G., Belfiore R., Althobaiti K. et al. Olink Target 96 MouseNeurologyPathophysiologyMouse Cell Supernatant | | | | |
Journal of Ethnopharmacology, 2026 OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study Chen G., Zhou S., Chen Y. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |